ArticleInternational journal of hematology2019

Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.

Takahiko Nakane et al.PubMed ↗Publisher ↗

No numbers read from the abstract.